EPCAM and breast carcinoma: EpCAM expression was detected in the majority of breast cancer specimens, with 26% showing high expression, 29% medium expression, and 31% low expression, indicating that EpCAM-NIR-PIT could be applicable to a large proportion of breast cancer cases (Figure 1A,B).